Report Code: A02354 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the U.s. Cardiac Troponin Market
Request Now !Cardiac markers are used as traceable substances while diagnosing patients with chest pain and suspected acute coronary syndrome (ACS). Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis. Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.
The growth of the U.S. cardiac troponin market is driven by increase in demand for cardiac biomarkers for cardiovascular disease diagnosis, rise in incidence of acute coronary syndrome (ACS), advancements in the cardiac biomarkers, and growth in demand for point-of-care cardiac testing kits. High specificity and sensitivity of these markers to detect any cardiac disorders and development of new products by the key market players contribute towards the market growth.
However, factors such as limited reimbursements and lack of precision while collecting sample impede the market growth. The development of multi-assay biomarkers and increase in awareness of cardiac troponin biomarkers in developing countries are expected to supplement the market growth in the near future.
The U.S. cardiac troponin market is segmented on the basis of product, application, and end user. Based on product, the market is categorized into cTn T, cTn I, and TnC. Applications covered in the study include acute coronary syndrome, myocardial infarction, congestive heart failure, and others. By end user, the market is bifurcated into laboratory testing and point of care testing.
The major players operating in this market include Abbott Diagnostics, Inc., F. Hoffmann-La Roche Ltd, bioMrieux SA, BG Medicine, Inc., Ortho-Clinical Diagnostics, Inc., Singulex, Inc., Alere, Inc., Siemens Healthcare Diagnostics, Inc., Beckman Coulter, Inc., and LifeSign LLC.
Key Benefits
U.S. Cardiac Troponin Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Abbott Diagnostics, Inc., Ortho-Clinical Diagnostics, Inc., BG Medicine, Inc., Alere, Inc., Siemens Healthcare Diagnostics, Inc., Singulex, Inc., bioMrieux SA, Beckman Coulter, Inc., LifeSign LLC, F. Hoffmann-La Roche Ltd. |
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 UNITED STATES CARDIAC TROPONIN MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CTN T
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CTN I
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. TNC
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 UNITED STATES CARDIAC TROPONIN MARKET, BY APPLICATIONS
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ACUTE CORONARY SYNDROME
5.2.1. Market size and forecast
5.3. MYOCARDIAL INFARCTION
5.3.1. Market size and forecast
5.4. CONGESTIVE HEART FAILURE
5.4.1. Market size and forecast
5.5. OTHERS
5.5.1. Market size and forecast
CHAPTER 6 UNITED STATES CARDIAC TROPONIN MARKET, BY END-USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LABORATORY TESTING
6.2.1. Market size and forecast
6.3. POINT OF CARE TESTING
6.3.1. Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. F. HOFFMANN-LA ROCHE LTD
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. BIOMÉRIEUX SA
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. ROCHE HOLDING AG
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ORTHO-CLINICAL DIAGNOSTICS, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. SINGULEX, INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ALERE, INC.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. SIEMENS HEALTHCARE DIAGNOSTICS, INC.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. BECKMAN COULTER, INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. LIFESIGN LLC
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers